Profile
Avestria Ventures is a venture capital firm based in the San Francisco Bay Area, specializing in women's health and female-led life science ventures. Founded by Harvard Business School classmates, the firm boasts a diverse team including partners like Linda Greub, CFA, and Tracy Dooley, MD. Its mission is to invest in overlooked and undervalued markets, focusing specifically on women’s healthcare and female founders in the life sciences, aiming to address the disparity in venture capital funding for these sectors.
Avestria Ventures targets early-stage businesses that utilize technology or data to improve healthcare quality and access while reducing costs. Their primary focus includes conditions affecting women exclusively or disproportionately. The firm supports companies that are evidence-based, capable of inducing clinical or behavioral change, and have scalable commercialization plans. While specific fund details vary, Avestria Ventures prioritizes strategic investments in healthcare that can leverage existing infrastructure and healthcare policies.
Notable portfolio companies include Axena Health, Clarified Precision Medicine, ENB Therapeutics, and Elucent Medical. Avestria Ventures is committed to empowering female founders and enhancing the landscape of women’s healthcare through strategic investments.
Industry
Avestria Ventures Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Avestria Ventures Fund I
|
Venture Capital (VC)
|
Biotechnology
Digital
Healthcare Services
Medical Devices
HealthTech
|
Seed
Series A
|
North America
|
$5-10 m
|
$50 M
|
July 2019
|
|
Avestria Ventures Fund II
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Medical Devices
Life Sciences
|
Seed
Series A
|
North America
|
$5-10 m
|
$100 M
|
June 2022
|
|
Women's Health and Female-Led Life Science Fund
|
Biotechnology
AI
MedTech
Life Sciences
HealthTech
|
Seed
Series A
Series B
|
North America
|
$1-5 m
|
—
|
September 2026
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.